Why the study?
Does the presence of LPL or APOE gene polymorphisms predict the risk of subclinical or clinical stroke in a middle-aged population?
Does the presence of LPL or APOE gene polymorphisms predict the risk of subclinical or clinical stroke in a middle-aged population?
The LPL S447X polymorphism is significantly associated with an increased risk of both subclinical cerebral infarction and incident clinical ischemic stroke in men, independent of traditional lipid levels.
No takes yet. Share an insight, caveat, or question.
Does not support incorporating LPL genotyping into stroke risk assessment; leaves open causal role and utility beyond traditional factors in men.
Morrison et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: